APA

Colombat P., Brousse N., Salles G., Morschhauser F., Brice P., Soubeyran P., Delwail V., Deconinck E., Haioun C., Foussard C., Sebban C., Tilly H., Thieblemont C., Bergougnoux L., Lazreg F. & Solal-Celigny P. (20121226). Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. : Annals of oncology : official journal of the European Society for Medical Oncology.

Chicago

Colombat P, Brousse N, Salles G, Morschhauser F, Brice P, Soubeyran P, Delwail V, Deconinck E, Haioun C, Foussard C, Sebban C, Tilly H, Thieblemont C, Bergougnoux L, Lazreg F and Solal-Celigny P. 20121226. Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. : Annals of oncology : official journal of the European Society for Medical Oncology.

Harvard

Colombat P., Brousse N., Salles G., Morschhauser F., Brice P., Soubeyran P., Delwail V., Deconinck E., Haioun C., Foussard C., Sebban C., Tilly H., Thieblemont C., Bergougnoux L., Lazreg F. and Solal-Celigny P. (20121226). Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. : Annals of oncology : official journal of the European Society for Medical Oncology.

MLA

Colombat P, Brousse N, Salles G, Morschhauser F, Brice P, Soubeyran P, Delwail V, Deconinck E, Haioun C, Foussard C, Sebban C, Tilly H, Thieblemont C, Bergougnoux L, Lazreg F and Solal-Celigny P. Rituximab induction immunotherapy for first-line low-tumor-burden follicular lymphoma: survival analyses with 7-year follow-up. : Annals of oncology : official journal of the European Society for Medical Oncology. 20121226.